Literature DB >> 34581780

MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated  serum creatine kinase.

Osorio Lopes Abath Neto1,2, Livija Medne3, Sandra Donkervoort1, Maria Elena Rodríguez-García4,5, Véronique Bolduc1, Ying Hu1, Eleonora Guadagnin1, A Reghan Foley1, John F Brandsema6, Allan M Glanzman6, Gihan I Tennekoon6, Mariarita Santi7, Justin H Berger8, Lynn A Megeney9, Hirofumi Komaki10, Michio Inoue10, Francisco Javier Cotrina-Vinagre4, Aurelio Hernández-Lain11, Elena Martin-Hernández5,12, Linford Williams13, Sabine Borell14, David Schorling14, Kimberly Lin8, Konstantinos Kolokotronis15, Uta Lichter-Konecki13, Janbernd Kirschner14,16, Ichizo Nishino10, Brenda Banwell3, Francisco Martínez-Azorín4,5, Patrick G Burgon17, Carsten G Bönnemann1.   

Abstract

Striated muscle needs to maintain cellular homeostasis in adaptation to increases in physiological and metabolic demands. Failure to do so can result in rhabdomyolysis. The identification of novel genetic conditions associated with rhabdomyolysis helps to shed light on hitherto unrecognized homeostatic mechanisms. Here we report seven individuals in six families from different ethnic backgrounds with biallelic variants in MLIP, which encodes the muscular lamin A/C-interacting protein, MLIP. Patients presented with a consistent phenotype characterized by mild muscle weakness, exercise-induced muscle pain, variable susceptibility to episodes of rhabdomyolysis, and persistent basal elevated serum creatine kinase levels. The biallelic truncating variants were predicted to result in disruption of the nuclear localizing signal of MLIP. Additionally, reduced overall RNA expression levels of the predominant MLIP isoform were observed in patients' skeletal muscle. Collectively, our data increase the understanding of the genetic landscape of rhabdomyolysis to now include MLIP as a novel disease gene in humans and solidifies MLIP's role in normal and diseased skeletal muscle homeostasis. Published by Oxford University Press on behalf of the Guarantors of Brain 2021.

Entities:  

Keywords:  MLIP; cardiomyopathy; hyperCKemia; myopathy; rhabdomyolysis

Mesh:

Substances:

Year:  2021        PMID: 34581780      PMCID: PMC8536936          DOI: 10.1093/brain/awab275

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   15.255


  16 in total

1.  Exome sequencing in Jewish and Arab patients with rhabdomyolysis reveals single-gene etiology in 43% of cases.

Authors:  Asaf Vivante; Hadas Ityel; Ben Pode-Shakked; Jing Chen; Shirlee Shril; Amelie T van der Ven; Nina Mann; Johanna Magdalena Schmidt; Reeval Segel; Adi Aran; Avraham Zeharia; Orna Staretz-Chacham; Omer Bar-Yosef; Annick Raas-Rothschild; Yuval E Landau; Richard P Lifton; Yair Anikster; Friedhelm Hildebrandt
Journal:  Pediatr Nephrol       Date:  2017-08-05       Impact factor: 3.714

Review 2.  Metabolic myopathies: a practical approach.

Authors:  James B Lilleker; Yann Shern Keh; Federico Roncaroli; Reena Sharma; Mark Roberts
Journal:  Pract Neurol       Date:  2017-12-09

3.  A systematic review on the definition of rhabdomyolysis.

Authors:  Kristina Stahl; Emanuele Rastelli; Benedikt Schoser
Journal:  J Neurol       Date:  2019-01-07       Impact factor: 4.849

4.  Bi-allelic Truncating Mutations in TANGO2 Cause Infancy-Onset Recurrent Metabolic Crises with Encephalocardiomyopathy.

Authors:  Laura S Kremer; Felix Distelmaier; Bader Alhaddad; Maja Hempel; Arcangela Iuso; Clemens Küpper; Chris Mühlhausen; Reka Kovacs-Nagy; Robin Satanovskij; Elisabeth Graf; Riccardo Berutti; Gertrud Eckstein; Richard Durbin; Sascha Sauer; Georg F Hoffmann; Tim M Strom; René Santer; Thomas Meitinger; Thomas Klopstock; Holger Prokisch; Tobias B Haack
Journal:  Am J Hum Genet       Date:  2016-01-21       Impact factor: 11.025

5.  Recurrent episodes of rhabdomyolysis in pontocerebellar hypoplasia type 2.

Authors:  Dimitrios I Zafeiriou; Athina Ververi; Anastasia Tsitlakidou; Athanasia Anastasiou; Euthymia Vargiami
Journal:  Neuromuscul Disord       Date:  2012-11-22       Impact factor: 4.296

6.  Marinesco Sjögren syndrome with rhabdomyolysis. A new subtype of the disease.

Authors:  W Müller-Felber; D Zafiriou; R Scheck; I Pätzke; M Toepfer; D E Pongratz; U Walther
Journal:  Neuropediatrics       Date:  1998-04       Impact factor: 1.947

7.  Identification of a novel muscle A-type lamin-interacting protein (MLIP).

Authors:  Elmira Ahmady; Shelley A Deeke; Seham Rabaa; Lara Kouri; Laura Kenney; Alexandre F R Stewart; Patrick G Burgon
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

8.  Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy.

Authors:  Ulrike Esslinger; Sophie Garnier; Agathe Korniat; Carole Proust; Georgios Kararigas; Martina Müller-Nurasyid; Jean-Philippe Empana; Michael P Morley; Claire Perret; Klaus Stark; Alexander G Bick; Sanjay K Prasad; Jennifer Kriebel; Jin Li; Laurence Tiret; Konstantin Strauch; Declan P O'Regan; Kenneth B Marguiles; Jonathan G Seidman; Pierre Boutouyrie; Patrick Lacolley; Xavier Jouven; Christian Hengstenberg; Michel Komajda; Hakon Hakonarson; Richard Isnard; Eloisa Arbustini; Harald Grallert; Stuart A Cook; Christine E Seidman; Vera Regitz-Zagrosek; Thomas P Cappola; Philippe Charron; François Cambien; Eric Villard
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

9.  Regulation of myonuclear positioning and muscle function by the skeletal muscle-specific CIP protein.

Authors:  Jianming Liu; Zhan-Peng Huang; Mao Nie; Gang Wang; William J Silva; Qiumei Yang; Paula P Freire; Xiaoyun Hu; Huaqun Chen; Zhongliang Deng; William T Pu; Da-Zhi Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

10.  Muscle Enriched Lamin Interacting Protein (Mlip) Binds Chromatin and Is Required for Myoblast Differentiation.

Authors:  Elmira Ahmady; Alexandre Blais; Patrick G Burgon
Journal:  Cells       Date:  2021-03-10       Impact factor: 6.600

View more
  5 in total

1.  Novel homozygous nonsense mutation of MLIP and compensatory alternative splicing.

Authors:  Jean Mezreani; Sébastien Audet; Florence Martin; Jade Charbonneau; Valérie Triassi; Eric Bareke; Annie Laplante; Jason Karamchandani; Rami Massie; Colin H Chalk; Erin O'Ferrall; Martine Tétreault
Journal:  NPJ Genom Med       Date:  2022-06-07       Impact factor: 6.083

2.  Cardiac ISL1-Interacting Protein, a Cardioprotective Factor, Inhibits the Transition From Cardiac Hypertrophy to Heart Failure.

Authors:  Youchen Yan; Tianxin Long; Qiao Su; Yi Wang; Ken Chen; Tiqun Yang; Guangyin Zhao; Qing Ma; Xiaoyun Hu; Chen Liu; Xinxue Liao; Wang Min; Shujuan Li; Dihua Zhang; Yuedong Yang; William T Pu; Yugang Dong; Da-Zhi Wang; Yili Chen; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2022-03-17

3.  Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson's disease.

Authors:  Yijing He; Kangwen Peng; Ruoyu Li; Zhuoyu Zhang; Lizhen Pan; Tianyu Zhang; Ao Lin; Ronghua Hong; Zhiyu Nie; Qiang Guan; Lingjing Jin
Journal:  J Neurol       Date:  2022-05-24       Impact factor: 6.682

4.  Cytokine release syndrome complicated with rhabdomyolysis after chimeric antigen receptor T-cell therapy: A case report.

Authors:  Lan Zhang; Wei Chen; Xiao-Min Wang; Shu-Qing Zhang
Journal:  World J Clin Cases       Date:  2022-09-16       Impact factor: 1.534

5.  Identification of feature genes and pathways for Alzheimer's disease via WGCNA and LASSO regression.

Authors:  Hongyu Sun; Jin Yang; Xiaohui Li; Yi Lyu; Zhaomeng Xu; Hui He; Xiaomin Tong; Tingyu Ji; Shihan Ding; Chaoli Zhou; Pengyong Han; Jinping Zheng
Journal:  Front Comput Neurosci       Date:  2022-09-21       Impact factor: 3.387

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.